BeStock  
Stocks › Drug Manufacturers - Specialty & Generic › NBIX

Neurocrine Biosciences NBIX

US equityMarket cap rank #693Drug Manufacturers - Specialty & Generic
$142.39 +$0.55 (+0.38%)
Market open · Oct 1, 11:50 am ET · After hours $141.00 -0.59%
Open$140.94
Prev close$141.84
Day range$140.54 – $143.01
Volume429.9K
Market cap$14.47B
P/E (TTM)20.8
Dividend yield–

NBIX Stock News

Headlines matching Neurocrine Biosciences or the NBIX ticker, most recent first.

  • Citi Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $253Market news · 4 Sep 2026
  • Citi Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $253Market news · 3 Sep 2026
  • UBS Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Cuts Target Price to $214Market news · 29 Sep 2026
  • Bernstein Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $218Market news · 26 Sep 2026
  • Neurocrine (NBIX) Receives a Buy From CCB Intl.TipRanks · 21 Sep 2026
  • RBC Capital Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $198Market news · 15 Sep 2026
  • Morgan Stanley Maintains Neurocrine Biosciences(NBIX.US) With Hold Rating, Raises Target Price to $183Market news · 11 Sep 2026
  • J.P. Morgan Reaffirms Their Buy Rating on Neurocrine (NBIX)TipRanks · 7 Aug 2026
  • J.P. Morgan Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Announces Target Price $217Market news · 7 Aug 2026
  • A Quick Look at Today's Ratings for Neurocrine Biosciences(NBIX.US), With a Forecast Between $194 to $249Market news · 4 Aug 2026
  • CCORF Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $210Market news · 3 Aug 2026
  • Citi Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $249Market news · 3 Aug 2026
  • Morgan Stanley Maintains Neurocrine Biosciences(NBIX.US) With Hold Rating, Maintains Target Price $182Market news · 25 Aug 2026
  • BMO Capital Maintains Neurocrine Biosciences(NBIX.US) With Hold Rating, Maintains Target Price $190Market news · 18 Aug 2026
  • Evercore Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $215Market news · 17 Aug 2026

Discussion

No comments yet — be the first to weigh in on NBIX.

Leave a comment

Scroll to Top